Deb Subrata, Puthanveetil Prasanth, Sakharkar Prashant
Department of Pharmaceutical Sciences, College of Pharmacy, Larkin University, Miami, FL 33169, USA.
Roosevelt University College of Pharmacy, Schaumburg, IL 60173, USA.
Int J Hepatol. 2018 Jun 3;2018:1286170. doi: 10.1155/2018/1286170. eCollection 2018.
To examine the association between low-density lipoprotein (LDL) and high-density lipoprotein (HDL) levels and liver enzyme functions.
The National Health and Nutrition Examination Survey (NHANES) data from 1999 to 2012 was used to examine the association between liver enzymes and lipid levels amongst adults in the United States.
Sixteen percent adults had ALT > 40 U/L, 11% had AST > 40 U/L, and 96% had ALP > 120 U/L. Age, gender, and race/ethnicity showed significant association with LDL, HDL, and triglycerides levels. LDL greater than borderline high was associated with little over two times higher odds of elevated ALT (OR: 2.33, 95% CI: 2.17, 2.53, ≤ 0.001) and AST (OR: 2.79, 95% CI: 2.55, 3.06, ≤ 0.001). High HDL was associated with 50% higher odds for elevated ALT (OR: 1.51, 95% CI: 1.39, 1.64, ≤ 0.001) and over two-and-half fold elevated AST (OR: 2.77, 95% CI: 2.47, 3.11, ≤ 0.001). LDL-C, HDL-C, and triglycerides were found to be good predictor of elevated ALT, AST, and ALP levels. Similarly, old age and female gender were significant predictor of elevated ALT and AST ( ≤ 0.001).
Underlying hepatic pathophysiology from dyslipidemia deserves further exploration due to its potential effects on hepatic drug metabolism/detoxification.
研究低密度脂蛋白(LDL)和高密度脂蛋白(HDL)水平与肝酶功能之间的关联。
使用1999年至2012年的美国国家健康与营养检查调查(NHANES)数据,研究美国成年人肝酶与血脂水平之间的关联。
16%的成年人谷丙转氨酶(ALT)>40 U/L,11%的成年人谷草转氨酶(AST)>40 U/L,96%的成年人碱性磷酸酶(ALP)>120 U/L。年龄、性别和种族/族裔与LDL、HDL和甘油三酯水平存在显著关联。LDL高于临界高水平与ALT升高几率高出两倍多相关(比值比:2.33,95%置信区间:2.17,2.53,P≤0.001)以及AST升高相关(比值比:2.79,95%置信区间:2.55,3.06,P≤0.001)。高HDL与ALT升高几率高50%相关(比值比:1.51,95%置信区间:1.39,1.64,P≤0.001)以及AST升高超过两倍半相关(比值比:2.77,95%置信区间:2.47,3.11,P≤0.001)。发现LDL-C、HDL-C和甘油三酯是ALT、AST和ALP水平升高的良好预测指标。同样,老年和女性是ALT和AST升高的显著预测指标(P≤0.001)。
血脂异常导致的潜在肝脏病理生理学因其对肝脏药物代谢/解毒的潜在影响值得进一步探索。